M12 logo

M1 Kliniken AG Stock Price

XTRA:M12 Community·€335.1m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 24 Fair Values set on narratives written by author

M12 Share Price Performance

€18.06
2.21 (13.94%)
€18.06
2.21 (13.94%)
Price €18.06

M12 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with high growth potential and pays a dividend.

1 Risk
4 Rewards

M1 Kliniken AG Key Details

€355.0m

Revenue

€307.4m

Cost of Revenue

€47.6m

Gross Profit

€29.8m

Other Expenses

€17.7m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
0.96
13.40%
5.00%
6.4%
View Full Analysis

About M12

Founded
2007
Employees
199
CEO
Attila Strauss
WebsiteView website
www.m1-kliniken.de

M1 Kliniken AG, together with its subsidiaries, provides aesthetic medicine and plastic surgery services in Germany, Austria, the Netherlands, Switzerland, the United Kingdom, Croatia, Hungary, Bulgaria, Romania, and Australia. It operates in two segments, Beauty and Trade. The Beauty segment provides aesthetic surgery services, such as breast augmentation, eyelid lifts, and liposuction; abdominoplastic and nose correction; and other aesthetic medical treatment services, including injections with hyaluronic acid and botulinum toxin. This segment also manages a private clinic for plastic and aesthetic surgery; and medical specialist centers for aesthetic and plastic medicine under the Schlossklinik and M1 Med Beauty names. The Trade segment sells pharmaceuticals and medical products for various therapeutic areas of oncology, HIV/AIDS, neurology, rheumatology, other chronic diseases, and aesthetic medicine. The company was incorporated in 2007 and is based in Berlin, Germany. M1 Kliniken AG is a subsidiary of MPH Health Care AG.

Recent M12 News & Updates

Recent updates

No updates